Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Northern Trust Corp

Northern Trust Corp boosted its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 7.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 245,110 shares of the company’s stock after acquiring an additional 16,421 shares during the period. Northern Trust Corp owned about 0.61% of Phibro Animal Health worth $5,147,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Phibro Animal Health by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock worth $31,809,000 after acquiring an additional 20,604 shares during the last quarter. American Century Companies Inc. raised its position in Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after acquiring an additional 96,787 shares during the last quarter. Renaissance Technologies LLC raised its position in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after acquiring an additional 10,600 shares during the last quarter. Geode Capital Management LLC raised its position in Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock worth $10,838,000 after acquiring an additional 8,510 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Phibro Animal Health by 35.6% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 322,090 shares of the company’s stock worth $6,764,000 after acquiring an additional 84,599 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analyst Upgrades and Downgrades

PAHC has been the subject of a number of recent research reports. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Finally, Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.00.

Phibro Animal Health Stock Performance

Shares of NASDAQ PAHC opened at $24.09 on Wednesday. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The company has a 50-day simple moving average of $20.19 and a 200-day simple moving average of $21.88. The company has a market cap of $976.46 million, a PE ratio of 50.19, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The firm had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. On average, equities analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.99%. Phibro Animal Health’s payout ratio is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.